Cargando…
Utility of Determining Autoantibodies to M-type Phospholipase A2 Receptor in Diagnosing Primary Membranous Nephropathy: An Ideal Setting
Autores principales: | Ramachandran, R., Kumar, V., Singh, N., Kataruka, M., Rathi, M., Kohli, H. S., Jha, V., Gupta, K. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590425/ https://www.ncbi.nlm.nih.gov/pubmed/28904444 http://dx.doi.org/10.4103/ijn.IJN_165_16 |
Ejemplares similares
-
The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation
por: Xipell, Marc, et al.
Publicado: (2018) -
CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy
por: Ramachandran, Raja, et al.
Publicado: (2016) -
Autoantibodies against Phospholipase A(2) Receptor in Korean Patients with Membranous Nephropathy
por: Oh, Yun Jung, et al.
Publicado: (2013) -
Long-Term Follow-Up of Cyclical Cyclophosphamide and Steroids Versus Tacrolimus and Steroids in Primary Membranous Nephropathy
por: Ramachandran, Raja, et al.
Publicado: (2021) -
Regulatory B Cells Are Reduced and Correlate With Disease Activity in Primary Membranous Nephropathy
por: Ramachandran, Raja, et al.
Publicado: (2020)